FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20231229E00252
1. Date of relevant event: 05/10/2023
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 06855
4. Name of listed corporation: Ascentage Pharma Group International - B 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 289,846,771
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) Yang
(Other names) Dajun
10. Name of director (Chinese): 楊大俊 
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1213The number of shares in which you are interested has reduced because:
any other event (you must briefly describe the relevant event in the Supplementary Information box)
 
 
 		 9,470         
 
Short position 
 
 
 		            
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position64,638,53122.30
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position64,629,06122.29
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2501Other (you must describe the capacity in the Supplementary Information box)
Long position64,335,559
2101Beneficial owner
Long position76,972
2202Interest of your spouse
Long position216,530
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
Long position
4105Unlisted derivatives - Physically settled
        46,972
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
SpouseZhai Yifan
Long position64,629,061
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
Ascentage LimitedWoodbourne Hall, P.O. Box 3162, Road Town, Tortola, British Virgin IslandsYang Dajun45.53Y
Long position64,629,061
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
Ascentage LimitedAddresses of individuals are not displayed.
Long position64,629,061
HealthQuest Pharma LimitedAddresses of individuals are not displayed.
Long position64,629,061
Zhai YifanAddresses of individuals are not displayed.
Long position64,629,061
Guo Edward MingAddresses of individuals are not displayed.
Long position64,629,061
Wang ShaomengAddresses of individuals are not displayed.
Long position64,629,061
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
Dajun Yang Dynasty TrustAddresses of individuals are not displayed.
5103Founder of a discretionary trust who can influence how the trustee exercises his discretion
Long position22,455,138
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: Dajun Yang held his interests in box 26 as beneficial owner, jointly with other persons, as a spouse, through interests in controlled corporation and as founder of a trust. Shares has been vested to Ms. Zhai, spouse of Mr. Yang, under 2022 RSU Scheme and 30,000 shares has been deliver to her on the date of relevant event. After tax deduction of 9,470 shares, 20,530 shares has been deposited.
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 29/12/2023
(dd/mm/yyyy)